Cargando…
Speed and need: twin development challenges in rapid response for a SARS-CoV-2 antibody cocktail
Neutralizing antibodies are one available tool for the treatment of infectious diseases. Speed in developing monoclonal antibody treatments is an understood requirement for emerging infectious diseases, and need for COVID-19 treatments during the worldwide pandemic has provided additional urgency. P...
Autores principales: | Lehman, Aimee, Muñiz, Virginia A., Chaney, Ryan, Pimentel, Joseph, Mattila, John, Lawrence, Shawn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920878/ https://www.ncbi.nlm.nih.gov/pubmed/35447504 http://dx.doi.org/10.1016/j.copbio.2022.102715 |
Ejemplares similares
-
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
por: Baum, Alina, et al.
Publicado: (2020) -
Rapid exploration of the epitope coverage produced by an Ebola survivor to guide the discovery of therapeutic antibody cocktails
por: Yuan, Tom Z, et al.
Publicado: (2020) -
A cocktail of antibodies for COVID-19 therapy
por: Matthews, Dean B.
Publicado: (2020) -
A counterintuitive antibody cocktail disrupts coxsackievirus
por: Zost, Seth J., et al.
Publicado: (2022) -
Antibody cocktail effective against variants of SARS-CoV-2
por: Liang, Kang-Hao, et al.
Publicado: (2021)